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Abstract 24 
Background: Impaired inhibitory control has been shown in individuals with substance 25 
use disorder (SUD). Cardiorespiratory fitness has been described as a potential factor to 26 
improve inhibitory control, however, the benefits in individual with SUD are unclear. 27 
Aims: To investigate the relationship between cardiorespiratory fitness with general and 28 
drug-specific inhibitory control in individuals with SUD. Methods: Sixty-two male 29 
participants under treatment for SUD performed a general and drug-specific inhibitory 30 
control test (Go/NoGo) and a cardiorespiratory fitness test. Results: Cardiorespiratory 31 
fitness, age and years of drug use were inversely associated with reaction time for both 32 
general and drug-specific inhibitory control. In addition, regression models show that 33 
cardiorespiratory fitness predicts general and drug-specific inhibitory control adjusted 34 
for age and time of drug use. However, cardiorespiratory fitness predicts equally both 35 
general and drug-specific inhibitory control. Conclusions: These findings suggest that 36 
increasing cardiorespiratory fitness could provide benefits in inhibitory function of 37 
individuals with SUD. 38 
Keywords: Drug addiction, aerobic exercise, alternative therapies, inhibitory control, 39 
cognition. 40 
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1. Introduction 45 
Chronic drug misuse is a worldwide public health problem. The Diagnostic and 46 
Statistical Manual of Mental Disorders of the American Psychiatric Association (DSM-47 
V 2013) classifies drug addiction as Substance Use Disorders (SUD) and Addictive 48 
Disorders. Several harmful consequences of SUD have been shown, including 49 
biological, mental, social, and financial problems (Beck & Heinz, 2013; Blanco-Gandía 50 
et al., 2015). In addition, SUD is also associated with metabolic and cardiovascular 51 
dysfunctions (Vongpatanasin, Taylor, & Victor, 2004; Whitman et al., 2017), increased 52 
risk of death (Fischbach, 2017) and harmful consequences to others including 53 
harassment, vandalism, physical aggression, and family problems (Nayak, Patterson, 54 
Wilsnack, Karriker-Jaffe, & Greenfield, 2019). The main neural mechanism associated 55 
with the persistent use of psychoactive substances is the release of dopamine 56 
neurotransmitter from the ventral tegmental area throughout the others areas in the 57 
reward system (i.e., nucleus accumbens, prefrontal cortex, striatum, and hippocampus) 58 
that leads to increased feelings of pleasure (Leshner, 1997). Repetitive drug use results 59 
in a decreased concentration of dopamine receptors (D2) in the reward system areas, 60 
leading to greater drug tolerance, abstinence, negative affect and craving feelings while 61 
provoking the urge to take higher doses (N. D. Volkow, Fowler, Wang, Baler, & 62 
Telang, 2009; Zorrilla & Koob, 2019). Chronically, this drug misuse also yields lower 63 
metabolic activity in the prefrontal cortex (PFC), while impairing higher order cognitive 64 
processes (i.e. executive functions) (Badre & Nee, 2018) and loss of control over drug 65 
seeking and behaviors (Goldstein & Volkow, 2011).  66 
Inhibitory cognitive control is one component of executive functioning and can 67 
be defined as the ability to inhibit habitual impulses or behaviors according to 68 
advantageous future consequences (Feil et al., 2010). When it comes to addictive 69 
 
 
 
behaviors, poorer performance in inhibitory control is related to impulsiveness, and may 70 
lead to further harmful consequences (Brewer & and Potenza, 2008). On the other hand, 71 
greater performance on the inhibitory control may favor reduced impulsiveness 72 
(Bechara, 2005a) and improve decision making related to drug-seeking behaviors 73 
(Bechara, 2005b; Shenoy & Yu, 2011). Furthermore, poorer response inhibition in 74 
individuals with SUD is associated with difficulties in resisting the consumption of drug 75 
substances especially when exposed to higher salient substance-related cues (Robinson 76 
& Berridge, 2008; Strickland et al., 2018; Weafer & Fillmore, 2012) increasing drug-77 
seeking and drug-taking behaviors (Fillmore & Rush, 2002; Fu et al., 2008; Luijten, 78 
Littel, & Franken, 2011; Rubio et al., 2008; Smith, Mattick, Jamadar, & Iredale, 2014; 79 
Volkow, Koob, & McLellan, 2016). Inhibitory control training have been suggested  as 80 
a method to improve inhibitory control towards addictive behaviors (Bos et al., 2019), 81 
however, its efficacy is still under investigation.  82 
In fact, different strategies have been proposed to treat drug addiction, such as 83 
pharmacotherapy, cognitive behavioral therapy and social support groups (Volkow & 84 
Li, 2005). However, it has been described a rate of 60% of relapse chances after 85 
treatment (Maisto, Pollock, Cornelius, Lynch, & Martin, 2003). Thus, new strategies are 86 
necessary to help the treatment of individuals with SUD.  Regularly-performed physical 87 
exercise (defined as planned and structured activity to cardiorespiratory fitness) 88 
(Caspersen, Powell, & Christenson, 1985) has been shown to induce several benefits on 89 
the human body and has been considered an important complementary tool to treat 90 
different pathologies, including those associated with the neural functioning (Pedersen 91 
& Saltin, 2015; Sallis, 2009). The practice of physical exercise may improve 92 
cardiorespiratory fitness (Garber et al., 2011), which is associated with reduced all 93 
causes mortality risk (Lee et al., 2011; Blair, Kohl III, Barlow, 1995) and lower risk of 94 
 
 
 
poorer health development (Blair, Cheng, & Holder, 2001). Physical exercise have 95 
already been suggested to benefit the treatment of patients with SUD by decreasing drug 96 
related behaviors, such as abstinence, consumption and craving (Buchowski et al., 2011; 97 
Wang, Wang, Wang, Li, & Zhou, 2014). However, few studies have investigated the 98 
benefits of physical exercise in cognitive functions using neurobiological markers in 99 
individuals with SUD. Crucially, this is important to develop physical activity treatment 100 
strategies aiming to improve cognitive function (Costa, Cabral, Hohl, & Fontes, 2019). 101 
For instance, previous research have demonstrated that acute exercise can 102 
decrease craving levels and abstinence feelings while improving inhibitory control 103 
(Wang, Zhou, & Chang, 2015; Wang, Zhou, Zhao, Wu, & Chang, 2016). Corroborating 104 
with this idea, we have also demonstrated that one single session of cycling exercise 105 
decreased drug craving feelings and increased PFC oxygenation in individuals with 106 
SUD, which was associated to higher inhibitory control performance (Grandjean da 107 
Costa et al., 2017). Recently, we have showed that greater cardiorespiratory fitness 108 
predicted better cardiac autonomic activity in response to an induced stressful situation 109 
in individuals with SUD (Cabral et al., 2019) while a 3-month running exercise program 110 
(3 times/week) improved PFC oxygenation, cardiac autonomic regulation, and 111 
inhibitory control in an alcoholic patient under treatment (Cabral et al., 2017). However, 112 
all of these studies have used general inhibitory cognitive measurements without drug 113 
cues (e.g., Color-Matching Stroop task), which might not trigger the 114 
psychophysiological responses related to drug cue-reactivity (i.e., increased heart rate 115 
and blood pressure, elevated cortisol and dopamine levels) (Papachristou, Nederkoorn, 116 
Havermans, Van Der Horst, & Jansen, 2012). To our knowledge, only two studies 117 
showed the benefits of aerobic exercise on an inhibitory cognitive task using drug-118 
specific pictures (i.e., drug-specific inhibitory control) (Wang et al., 2015; Wang, Zhu, 119 
 
 
 
Zhou, & Chang, 2017a). However, these studies did not measure cardiorespiratory 120 
fitness, which make it difficult to infer any associations between the chronic exercise 121 
adaptations and cognitive response to drug-specific inhibition. Thus, we believe that, by 122 
improving the understanding of the link between cardiorespiratory fitness and drug-123 
specific inhibitory control, we may bring new insights regarding the treatment of 124 
individuals with SUD.  125 
Here we investigate the relationship between cardiorespiratory fitness and 126 
cognitive performance on a general and drug-specific inhibitory control task in 127 
individuals with SUD. We hypothesize that cardiorespiratory fitness would be 128 
associated with enhanced inhibitory control in individuals with SUD. We further predict 129 
that this association will be higher with drug-specific inhibitory control. 130 
Methods 131 
2.1 Participants 132 
The study initially composed of 76 male adults under treatment for substance 133 
use disorder at five different rehabilitation community settings that are free of 134 
medications on their routine rehabilitation practice. To be eligible in this study, 135 
participants had to score the minimum of 24 points on the MMSE (Batista, Klauss, 136 
Fregni, Nitsche, & Nakamura-Palacios, 2015) and be approved on the physical activity 137 
screening questionnaire (PAR-Q) (Roy J, 1988) by answering “No” to all questions. 138 
There were no exclusion criteria for a specific substance. Sixty-two volunteers were 139 
used in the final sample. 14 individuals were excluded since they did not reached 140 
minimum score of 24 points on Mini-Mental State Examination (MMSE) and/or were 141 
not approved on the cardiac risk screening questionnaire (PAR-Q) (Roy J, 1988). The 142 
preferred substances of each participant (alcohol, nicotine, marijuana, cocaine/crack, 143 
 
 
 
LSD, amphetamines, hypnotic sedatives, and ecstasy) were defined by applying the 144 
Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) (Henrique, 145 
Iara Ferraz Silva; Micheli, De Lacerda, De Lacerda, & Formigoni, 2008). Among the 146 
participants, 33 were multiple drug users (25 alcohol/crack, 4 crack/marijuana, 2 147 
Alcohol/Marijuana, 2 Crack/Marijuana/Alcohol) and 15 were crack/cocaine users, 3 148 
were marijuana users, 11 were alcohol users. All participants met at least two criteria for 149 
Substance Use Disorder from the DSM-V (Hasin et al., 2013). The study followed the 150 
Declaration of Helsinki standards and all participants signed the informed consent 151 
approved by the local ethics committee  152 
2.2 Experimental Design 153 
This cross-sectional study was performed in three visits at different 154 
rehabilitation community settings with a minimum interval of 48 hours between each 155 
visit. On the first visit, patients attended a lecture describing the harmful effects of 156 
drugs on the brain and the benefits of physical exercise. At the end, the study purposes 157 
and procedures were presented. On the second visit, the patients that agreed to 158 
participate in our study completed questionnaires for psychosocial state assessment, 159 
physical activity readiness (PARQ) and drug-specific risk status. On the third visit, the 160 
participants completed the general and drug-specific inhibitory task followed by the 161 
cardiorespiratory fitness test.  162 
2.3 Measurements 163 
2.3.1 Psychosocial Questionnaire 164 
Psychosocial questionnaire for stress, anxiety and depression (DASS-21) was 165 
administered to the participants (Ribeiro, Honrado, & Leal, 2004). The DASS-21 166 
consists of three scales of seven items each (total of 21 items). Each item consists of a 167 
 
 
 
phrase or statement referring to negative emotional symptoms. For each sentence there 168 
is a choice of four possible responses, presented on a Likert scale (e.g., 0 Did not apply 169 
to me at all; 1 Applied to me to some degree, or some of the time; 2 Applied to me to a 170 
considerable degree or a good part of time; 3 Applied to me very much or most of the 171 
time. The participants carried out the test in a quiet environment and in a reserved room. 172 
The DASS-21 score was quantified through three scales: depression, anxiety and stress, 173 
deriving scores for depression – dysphoria (two items); Discouragement, (two items); 174 
Life devaluation (two items); Auto depreciation (two items); Lack of interest or 175 
involvement (two items); Anhedonia (two items); Inertia (two items). Anxiety – 176 
excitation of the autonomous system (five items); Skeletal muscle effects (two items); 177 
Situational anxiety (three items); Subjective experiences of anxiety (four items). Stress 178 
– Difficulty in relaxing (three items); Nervous excitation (two items); Easily 179 
agitated/upset (three items); Irritable/exaggerated reaction (three items); Impatience 180 
(three items). 181 
2.3.2 ASSIST Questionnaire 182 
This questionnaire, developed by the World Health Organization (Group, 2002), 183 
assesses the risks and problems related to the use of alcohol, marijuana, cocaine/crack, 184 
LSD, sedatives, hallucinogens, heroin, Inhalants, opioids, and other drugs. The 185 
questionnaire consists of seven questions that include a score and classifies the 186 
individual as being without the need for intervention (< 3 pts), needing a brief 187 
intervention (> 4 pts), or a need of immediate intervention (> 27 pts) according to the 188 
preferred drug. In this study, the ASSIST was used to identify the drug of preference, 189 
since all volunteers were on a regimented treatment. 190 
2.3.3 Cardiorespiratory Fitness Test 191 
 
 
 
The participants initially had their weight and height assessed followed by the 192 
multistage 20-m shuttle run (a progressive effort test) proposed by Leger (1988). This 193 
test has been demonstrated to indirectly predict the VO2max. A Meta-analysis showed 194 
that this test has been validated and has good reliability predicting VO2max (Mayorga-195 
Vega, Aguilar-Soto, & Viciana, 2015 (Léger, Mercier, Gadoury, & Lambert, 1988). In 196 
this test, the participants are asked to run from one cone to another cone with a fixed 197 
distance of 20m between them, and reversing the direction at each cone, thus returning 198 
to the opposite one. The running pace should occur according to the sound signals 199 
emitted by an audio recording specifically for this test. Initial speed was 8.5 km/h, with 200 
an increasing of 0.5 km/h each minute. An exception was given at the first minute, with 201 
an increase of 1 km/h. As the test speed increases, the interval between the sound 202 
signals decreases. The test was finished when the participant interrupted its 203 
displacement by voluntary exhaustion (ratings of perceived exertion = 10 on CR-10 204 
Borg Scale) (Borg, G., Linderholm, 1970) or had not been at least 2m apart from the 205 
cone at the sound signal for two times, not necessarily consecutive times. The 206 
estimative of maximum oxygen consumption (VO2max) was calculated (VO2 =(Y) = -207 
24.4) + [(6.0*X)] (Y = ml/kg/min; X = velocity in km/h at the stage reached). 208 
2.3.4 Go/no-go inhibitory control task  209 
An adapted go/no-go inhibitory control task was developed based on previous 210 
study with food related images (Price, Lee, & Higgs, 2016). For the drug-specific trials, 211 
images of marijuana, crack, cocaine and alcoholic beverages were used as no-go 212 
images. For the neutral trials, sports images were used as no-go images. In both cases, 213 
the go images were bathroom objects. All drug specific images were taken from the 214 
database “addiction pics” for experimental researchers 215 
(https://pixabay.com/pt/photos/addiction/). Images with other objects were taken from 216 
 
 
 
the BOSS normative database of photographs of objects (Brodeur, Dionne-Dostie, 217 
Montreuil, & Lepage, 2010).  Images were randomly presented on a computer screen 218 
with a ratio of 20% (No Go) and 80% (Go). The presentation order of the drug-specific 219 
task and neutral task was counterbalanced. The individuals were told to press the space 220 
key button as fast as possible whenever they see a bathroom object (Go) and to not 221 
press the space key when the image was drug-cue or sports (neutral) images as relevant 222 
(No Go). Two hundred images were presented in total. Each image was shown on the 223 
screen for 750ms. Intercalating each image, a blank screen (500ms) and another screen 224 
with a “+” (fixing point for 500ms) were presented (Figure 1). Between each drug 225 
image and sports images, bathroom images were randomly inserted (3, 4 or 5 between 226 
every cue picture). The total test lasted approximately 7 minutes. Inhibitory control was 227 
evaluated by the number of times the space bar was pressed incorrectly in no-go trials 228 
(commission errors) and by reaction times (ms) on Go trials. Instructions were 229 
standardized and comprehension and willingness of the participants were assured by a 230 
short preceding practice trial. Drugs images were selected according to the drug 231 
preference of each subject. For example, if an individual was considered as a cocaine 232 
and alcohol user (multiple drug user), images of both drugs would be used during the, 233 
No Go trials. 234 
Figure 1. General and drug-specific cognitive inhibitory task. 235 
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 243 
2.4 Statistical analysis 244 
The Shapiro-wilk test was used to verify data normality and Levene’s test was 245 
performed to check data homogeneity. Parametric data are described as mean ± standard 246 
deviation and non-parametric variables as median (confidence interval) (see table 1). 247 
Initial Spearman correlations were conducted for the variables of interest (commission 248 
errors and reaction time of go no/go task, VO2max). Potential covariables (age, time of 249 
drug use, body mass index (BMI), days in abstinence, and DASS-21 scores) were also 250 
included on the correlation analysis. Significant covariables were included in the main 251 
regression analysis. Multiple linear regression analyses were applied to investigate the 252 
independent contribution of VO2max to the variance in inhibitory control parameters. 253 
Assumptions of equality of variance, independence, linearity and normality were 254 
plotted, inspected, and verified using Studentized residuals. Multicollinearity was not 255 
observed among any of the independent variables. Statistical significance was set at 256 
p<0.05 and was used bootstrapping power analysis values are described in CI 257 
(Banjanovic & Osborne, 2016). We used the software SPSS® 22.0 for Windows (SPSS, 258 
Inc., Chicago, IL). 259 
 260 
2. Results 261 
Bivariate correlations (2-tailed) showed that cardiorespiratory fitness (VO2max) 262 
was inversely associated with age (r = -.46, p<.001), time of drug use (r = -.52, p<.001) 263 
and reaction time for general (r = -.43, p<.001), and drug-specific inhibitory control (r = 264 
-.47, p<.001).  No associations were found between VO2max with BMI (r = -.04, 265 
p<.709), days in abstinence (r = -.02, p<.851), and DASS-21 scores (stress: r = -.02, 266 
 
 
 
p<.832; anxiety: r = -.11, p<.360; depression: r = -.13, p<.286). In addition, no 267 
association was found between commission errors and cardiorespiratory fitness (general 268 
inhibitory control errors (r = -.16, p<.189), and drug-specific inhibitory control errors (r 269 
= -.07, p<.580). Therefore, two multiple regression analyses were run for predicting 270 
reaction time on the general and drug-specific trials of the go/no-go task (see Table 2). 271 
Results show that cardiorespiratory fitness (VO2max) predicts the reaction time for 272 
general [F (6; 3); (t = -3.0; β = -.41; p = .003] and drug-specific inhibitory control [F (8; 273 
3); t = -3.2; β = -.42; p < .002] when we adjusted the analyses for age and time of drug 274 
use. 275 
Sample general characteristics  
 
Median (CI) (n=62) 
 
Age 34 (31.9 – 36.4) 
 
BMI (kg/m²) # 
 
24.6 ± 2.9 
 
VO2max (ml/kg/min)  
 
39 (38.4 – 42) 
 
Time of drug use (yrs) 13 (12.9 – 18.3) 
 
DSM-V (pts) 5.7 (5.2 – 6.2) 
 
Abstinence use (days)  105 (103 – 173.6) 
 
Anxiety (a.u) 
 
28.5 (24.7 – 37.2)  
 
Depression (a.u) 
 
23.8 (22.3 – 33.8) 
 
Stress (a.u) 
 
23.8 (23.8 – 34.6) 
 
 
Commission errors (general) 2 (1.7 - 2.8) 
 
Commission errors (specific) 1 (1.2 - 2.1) 
 
RT (general) (ms) # 482.5 ± 56.3  
 
RT (specific) (ms) # 
 
498.9 ± 61.5 
 
 
 
 
Table I. Describes the sample general characteristics and cognitive performance on the 276 
go/no-go task. 277 
 278 
Legend. RT (Reaction time) #Mean and standard deviation; BMI: body mass index; DSM-V: 279 
Substance Use Disorders. 280 
  Table 2.  Regression analyses between cardiorespiratory fitness and reaction time of 281 
general              and specific inhibitory control adjusted by age and time of drug use. 282 
Predictors 
 Reaction time (General)  Reaction time (Drug-specific) 
 β (CI) ΔR2  β (CI) ΔR2 
Model 1   .13   .16 
Age  .34* (09 – 54)   .43** (15 – 60)  
Time of Drug use  .03 (04 – 49)   .00 (03 – 54)  
Model 2   .25   .27 
Age  .23 (09 – 54)   .32 (15 – 60)  
Time of Drug use  -.10 (04 – 49)   -.13 (03 – 54)  
VO2max  -.41** (- 62 – - 19)   -.42** (- 66 – - 23)  
*p<0.05; **p<0.01 283 
  284 
Discussion  285 
Drug preferences N (%) 
 
Crack/Cocaine 15 (24.1) 
 
Marijuana 3 (4.8) 
 
Alcohol 11 (17.7) 
Crack/Alcohol 25 (40.3) 
Crack/Marijuana 4 (6.4) 
Alcohol/Marijuana 2 (3.2) 
Crack/Marijuana/Alcohol 2 (3.2) 
 
 
 
The present study sought to investigate whether cardiorespiratory fitness was 286 
associated with performance on a general and drug-specific inhibitory control task in 287 
individuals with SUD. We found that higher cardiorespiratory fitness predicted better 288 
performance on the cognitive test when controlling for age and length of time using the 289 
drug.  However, cardiorespiratory fitness was not associated with stress, depression or 290 
anxiety scores and we could not find differences between general and specific inhibitory 291 
control performance predicted by cardiorespiratory fitness. Nevertheless, our results 292 
indicate the importance of cardiorespiratory fitness in cognitive control deficits in 293 
individuals with SUD. 294 
 Physical exercise is fundamentally important in the evolutionary history of 295 
human beings (Bramble and Lieberman, 2004), aiding survival in hunter-gatherer 296 
societies. Findings have demonstrated that levels of cardiorespiratory fitness during 297 
human evolution are correlated with increases in brain size, with the PFC being the 298 
most developed neural area when compared to any other primates (Raichlen & Polk, 299 
2012). The cognitive functions of the PFC have been suggested to play role in exercise 300 
tolerance and performance (Robertson & Marino, 2016), with a cohort study revealing a 301 
preventive effect of exercise on drug use. In fact,  McElrath and colleagues showed that 302 
individuals that performed physical exercise regularly were less likely to consume 303 
alcohol, cigarettes, and marijuana (McElrath, O’Malley, & Johnston, 2011). Thus, we 304 
speculate that our results showing that individuals with higher cardiorespiratory fitness 305 
have better inhibitory control may be related to these preventive effects on drug use. 306 
Individuals with SUD have been  shown to display impairments of inhibitory control 307 
and PFC function during exercise (Grandjean da Costa et al., 2017), which could 308 
hamper exercise adherence and, consequently, the development of cardiorespiratory 309 
fitness. Previous research has also shown that exercise practice can be an effective 310 
 
 
 
complementary treatment for SUD rehabilitation (Weinstock, Farney, Elrod, 311 
Henderson, & Weiss, 2018). To date, most of the research that has analyzed the effects 312 
of physical exercise on behavioral outcomes in drug addiction, have not attempted to 313 
explore the mechanism of change (Wang et al., 2015; Wang, Zhu, Zhou, & Chang, 314 
2017a). We have shown that cardiorespiratory fitness is related to inhibitory control in 315 
individuals with SUD, suggesting that the benefits of physical exercise in improving 316 
cardiorespiratory fitness may be related to improvements in inhibitory control. 317 
However, due to the cross-sectional nature of this study we cannot establish causality 318 
and longitudinal research is needed to confirm this assumption.  319 
Typically, the commission errors during Go/No go tasks are the main parameter 320 
for inhibitory control performance. In our study, few commission errors were made, and 321 
may have induced a floor effect whereas the recorded data was unable to discriminate 322 
among the participants´ cognitive performance (Catts, Petscher, Schatschneider, 323 
Bridges, & Mendoza, 2009). Thus, we believe that this may help to explain why we did 324 
not find associations between cardiorespiratory fitness and commission errors. 325 
However, we did find an association between cardiorespiratory fitness and reaction 326 
times, which has also been indicated as a parameter of cognitive performance 327 
(Papachristou et al., 2012). In go/no-go tasks, slower reaction time in the go trials can 328 
indicate increased difficulty in inhibiting the response on the no go trials via a speed-329 
accuracy trade-off (Bogacz, Wagenmakers, Forstmann, & Nieuwenhuis, 2010). In fact, 330 
previous studies used mean reaction time on the go condition as measure of inhibitory 331 
control performance (Smith et al., 2011; Wang, Zhu, Zhou, & Chang, 2017b). Thus, 332 
reaction time can also be used as an efficiency index of cognitive performance (Hirose et 333 
al., 2012), and we infer that better inhibitory control in individuals with higher 334 
 
 
 
cardiorespiratory fitness, as they performed the same amount of correct answers while 335 
having faster reaction time.  336 
Few studies have investigated the relationship between physical exercise with 337 
general  and drug-specific inhibitory control in individuals with SUD. Our results found 338 
that cardiorespiratory fitness independently predicts reaction time for general and drug-339 
specific inhibitory control, which indicates the possible benefits of having higher 340 
cardiorespiratory fitness on cognition of individuals with SUD. Several studies have 341 
demonstrated the benefits of cardiorespiratory fitness on cognition in different 342 
populations (Colcumbe et al., 2006; Hillman, Erickson, & Kramer, 2008; Kramer, 343 
2009). These benefits might also be transposed to SUD individuals as shown in our 344 
study. These findings have been discussed in terms of the effects of exercise on 345 
neuroplasticity in the prefrontal cortex, which may enhance executive functions (Maass 346 
et al., 2016).  Therefore, we highlight the importance of investigating the effects of 347 
exercise on cognition in individuals with SUD to provide further understanding of the 348 
rehabilitation alternative methods.  349 
However, we could not find differences between the associations of 350 
cardiorespiratory fitness and performances on the general and drug-specific inhibitory 351 
control. One possible explanation for this finding could be that the VO2 max 352 
measurement in our study is an indirect measure and may not be a reliable indicator of 353 
cardiovascular fitness in individuals SUD. It may be the case that the drug-specific 354 
inhibitory control test is only sensitive to laboratory-based tests of VO2max. Moreover, 355 
despite we have used specific images of drug cues for the drug preference of each 356 
individual, we speculate that these cues did not produce a physiological cue-reactivity 357 
response in order to difficult the inhibition process. Further studies measuring 358 
physiological markers (i.e. Heart rate variability, skin conductance, electrocortical 359 
 
 
 
activity) could help to evaluate such responses. For instance, studies have shown that 360 
cue-reactivity responses induce feelings of cravings that activate brain frontal areas and 361 
predict relapse in individuals with SUD (Wilson, Sayette, & Fiez, 2004). On the other 362 
hand, randomized control trials have failed to translate inhibitory control training to 363 
changes in addictive behaviors interventions (Bos et al., 2019; Jones et al., 2018). Thus, 364 
further studies are necessary to test if there is a difference in physiological and 365 
behaviors responses between drug-specific inhibitory and general inhibitory control in 366 
the drug-specific go/no-go task proposed in our study. 367 
We do acknowledge that our study is potentially limited by the heterogeneity of 368 
the sample in terms of preferred drug and the small sample for each subgroup of drug 369 
use (cocaine/crack, alcohol, marijuana). This may have affected the cue-reactive 370 
responses during the drug-specific inhibitory control due to the different action 371 
mechanisms promoted by the drugs. However, studies have shown that all of these 372 
drugs impair PFC function and inhibitory control performance (Herbsleb et al., 2013; 373 
Luijten et al., 2014; Nora D. Volkow et al., 2016), which was the investigative focus of the 374 
present study. In this preliminary research study, we also did not have a healthy control 375 
group, which could have helped to further compare the benefits of cardiorespiratory 376 
fitness in inhibitory control. However, we believe that our findings are useful to guide 377 
future research in this area. We also did not use any neurobiological measurement (e.g., 378 
MRI, EEG), which could have masked some cerebral differences between the two 379 
inhibitory tasks. Future research should try to replicate our study but using some neural 380 
instrument. Based on our findings, further longitudinal studies with specific samples of 381 
SUD are necessary to test the efficacy of the drug-specific go/no-go task used in this 382 
study as an indicator of cognitive changes associated to improvements in 383 
cardiorespiratory fitness. 384 
 
 
 
Clinical Implications  385 
Our results suggest that improved cardiorespiratory fitness might be beneficial to 386 
inhibitory control in individuals with SUD. However, to date, there is no specific 387 
exercise prescription for patients with SUD. Thus, we suggest that professionals from 388 
therapeutic community settings apply the prescription based on the American College of 389 
Sports Medicine (ACSM) guidelines (Garber et al., 2011) which includes light to 390 
moderate intensity exercise for 150 minutes or more per week. Moreover, we believe 391 
that the PFC impairments in individuals with SUD might have a disadvantage on 392 
internal exercise regulatory process that may impact the adherence to exercise programs 393 
(Grandjean da Costa et al, 2019). We suggest that activities that promote higher 394 
distraction from internal cues, such as adding music, outdoors environment and group 395 
training might be important strategies to increase affective feelings while exercising. As 396 
a complement to the training program, future research could use the drug-specific 397 
cognitive task to understand the changes induced by long term exposure to chronic 398 
exercise programs.  399 
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